137 related articles for article (PubMed ID: 4040500)
1. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction.
Tada M; Hoshida S; Kuzuya T; Inoue M; Minamino T; Abe H
Int J Cardiol; 1985 Jul; 8(3):301-12. PubMed ID: 4040500
[TBL] [Abstract][Full Text] [Related]
2. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
[TBL] [Abstract][Full Text] [Related]
3. Development of an experimental model of acute myocardial infarction and the effects of a thromboxane synthetase inhibitor (OKY-046).
Tomoda H
Am Heart J; 1986 Oct; 112(4):696-704. PubMed ID: 3532743
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
Burke SE; Lefer DJ; Lefer AM
Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
[TBL] [Abstract][Full Text] [Related]
5. Selective thromboxane synthetase inhibitor and ischemic heart disease.
Ito T; Ogawa K; Watanabe J; Chen LS; Shikano M; Imaizumi M; Shibata T; Ito Y; Miyazaki Y; Satake T
Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
[No Abstract] [Full Text] [Related]
6. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
Moriuchi M
Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
[No Abstract] [Full Text] [Related]
7. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
[TBL] [Abstract][Full Text] [Related]
8. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium.
McCluskey ER; Kramer JB; Corr PB; Needleman P
Biochem Biophys Res Commun; 1984 Jun; 121(2):552-7. PubMed ID: 6539597
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock.
Fukumoto S; Tanaka K
Prostaglandins Leukot Med; 1983 Jun; 11(2):179-88. PubMed ID: 6576388
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
Mehta J; Mehta P; Ostrowski N
Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
[No Abstract] [Full Text] [Related]
12. Selective thromboxane A2 synthetase inhibition in vasospastic angina pectoris.
Yui Y; Hattori R; Takatsu Y; Kawai C
J Am Coll Cardiol; 1986 Jan; 7(1):25-9. PubMed ID: 3941213
[TBL] [Abstract][Full Text] [Related]
13. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
Gomi T; Ikeda T; Ishimitsu T; Uehara Y
Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
[TBL] [Abstract][Full Text] [Related]
14. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
[No Abstract] [Full Text] [Related]
15. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
[TBL] [Abstract][Full Text] [Related]
16. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
[No Abstract] [Full Text] [Related]
17. Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist.
Nichols WW; Mehta J; Wargovich TJ; Franzini D; Lawson D
Angiology; 1989 Mar; 40(3):209-21. PubMed ID: 2537051
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary vascular response to thrombin: effects of thromboxane synthetase inhibition with OKY-046 and OKY-1581.
Garcia-Szabo R; Kern DF; Malik AB
Prostaglandins; 1984 Dec; 28(6):851-66. PubMed ID: 6543018
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane A2 in acute myocardial infarction.
Walinsky P; Smith JB; Lefer AM; Lebenthal M; Urban P; Greenspon A; Goldberg S
Am Heart J; 1984 Oct; 108(4 Pt 1):868-72. PubMed ID: 6485997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
